Actinobacteria Metabolic Engineering
This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
The growing resistance towards established antibiotics presents a serious problem especially with infectious diseases. The development of new drugs is mainly based on known molecules and mechanisms, which allows bacteria to assimilate rapidly. Hence, scientists are looking for novel drugs. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a branch of the Helmholtz Centre for Infection Research (HZI) at Braunschweig, the researchers develop new pathways, by which they force actinomycetes to produce hitherto unknown compounds.
Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!